January 16, 2020

Biosimilars – 2019 Year in Review

Life sciences attorneys John Adkisson, Tasha Francis, and Jenny Shmuel provide a review of current legal and regulatory developments that have had an impact on the U.S. biosimilar industry. Topics discussed during this webinar include:

  • 2019 biosimilar approvals, launches, and anticipated launches
  • Summary of FDA guidance in 2019
  • Updates regarding pending court cases and appellate decisions
  • 2019 IPR trends
  • What to look forward to in 2020!

Download a copy of the slides here

John Adkisson
Tasha Francis, Ph.D.
Jenny Schmuel, Ph.D.

No Comments

Sorry, the comment form is closed at this time.